← Back to Clinical Trials
Recruiting NCT07144436

NCT07144436 Post-stroke Pain tAN-fMRI

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07144436
Status Recruiting
Phase
Sponsor Medical University of South Carolina
Condition Post Stroke Pain
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2026-01-08
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Transcutaneous Auricular Neurostimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2026-01-08 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to explore whether 4 weeks of at-home transcutaneous auricular neurostimulation (tAN) can reduce chronic pain after a stroke. Investigators will recruit up to 24 participants with chronic post-stroke upper extremity pain. The goal is to determine if there is a pain reduction after ear stimulation.

Eligibility Criteria

Inclusion Criteria: * Age 18-80 * Have the capacity and ability to provide one's own consent in English and sign the informed consent document. * Ischemic or hemorrhagic stroke that occurred at least 6 months prior Exclusion Criteria: * Primary intracerebral hematoma or subarachnoid hemorrhage * Documented history of dementia * Documented history of uncontrolled depression or psychiatric disorder * Uncontrolled hypertension despite treatment, specifically SBP (Systolic Blood Pressure) / DBP (Diastolic Blood Pressure) \>=180/100mmHg * Contraindicated for MRI scanning * Pregnancy

Contact & Investigator

Central Contact

Institutional RBFHR Recruitment Contact

✉ suttonf@musc.edu

📞 843-792-9502

Principal Investigator

Xiaolong Peng, Ph.D.

PRINCIPAL INVESTIGATOR

Medical University of South Carolina

Frequently Asked Questions

Who can join the NCT07144436 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Post Stroke Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07144436 currently recruiting?

Yes, NCT07144436 is actively recruiting participants. Contact the research team at suttonf@musc.edu for enrollment information.

Where is the NCT07144436 trial being conducted?

This trial is being conducted at Charleston, United States, Charleston, United States.

Who is sponsoring the NCT07144436 clinical trial?

NCT07144436 is sponsored by Medical University of South Carolina. The principal investigator is Xiaolong Peng, Ph.D. at Medical University of South Carolina. The trial plans to enroll 24 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology